Thomas Jefferson University, Sidney Kimmel Cancer Center — Philadelphia, Pennsylvania

Thomas Jefferson University, Sidney Kimmel Cancer Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Thomas Jefferson University, Sidney Kimmel Cancer Center has participated in 24 clinical trials with 13 currently active.

Therapeutic areas: Sarcoma, Melanoma, Lung Cancer.

Sponsors: Prelude Therapeutics, BicycleTx Limited, EvolveImmune United, Inc.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Thomas Jefferson University, Sidney Kimmel Cancer Center?

Thomas Jefferson University, Sidney Kimmel Cancer Center has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Thomas Jefferson University, Sidney Kimmel Cancer Center conducted?

Thomas Jefferson University, Sidney Kimmel Cancer Center has 24 clinical trials on record, with 13 currently active. Their work covers Sarcoma, Melanoma, Lung Cancer.

Is Thomas Jefferson University, Sidney Kimmel Cancer Center accredited by Crixeo Health?

Thomas Jefferson University, Sidney Kimmel Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Thomas Jefferson University, Sidney Kimmel Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.